Evidence-Based Medicine’s Success May Shift Definition Of Proprietary Data
Executive Summary
As more emphasis is placed on the use of evidence-based medicine to help drive health plan coverage and physician prescribing decisions, providers' information needs may force manufacturers to change their viewpoints on what defines proprietary data
You may also be interested in...
Benzodiazepine Coverage Among Medicare Provisions In Child Health Bill
Makers of benzodiazepines could see wider use of their products by Medicare Part D enrollees, under a provision of the child health/Medicare legislative package that cleared the House Ways and Means Committee July 27
Trial Registry Bill Should Request Protocol With Results, FDA’s Temple Says
Any proposal to expand the ClinicalTrials.gov registry that does not require submission of trial protocols "does not do the whole job," FDA Office of Medical Policy Director Robert Temple said at a June 19 session of the Drug Information Association in Atlanta
AHRQ Issues “User’s Guide” On Patient Registries As Tool For Researchers
A guide to patient outcome registries, published by the Agency for Healthcare Research and Quality May 16, will serve as a reference for researchers and not affect regulatory expectations